SCHEMBL16664914

SCHEMBL16664914

Sc1ccnc2c1OCC2

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25263347 0.76 PARP1 (0.30) PARP1
SCHEMBL30259052 0.76 PARP1 (0.30) PARP1
SCHEMBL14451069 0.76 CCR1 (0.34) PARP1
SCHEMBL25064264 0.76 MAPK13 (0.30) PARP1
SCHEMBL30364177 0.76 MAPK13 (0.30) PARP1
SCHEMBL12395081 0.73 ATM (0.34)
SCHEMBL30525181 0.71 PARP1 (0.56) PARP1
SCHEMBL22838646 0.69 HTR2A (0.33)
SCHEMBL25223217 0.66
SCHEMBL30258819 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015058031-A1 DNA-PK INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-04-23 WO disclosed